コンテンツへスキップ
Merck
  • Notch regulates vascular collagen IV basement membrane through modulation of lysyl hydroxylase 3 trafficking.

Notch regulates vascular collagen IV basement membrane through modulation of lysyl hydroxylase 3 trafficking.

Angiogenesis (2021-05-07)
Stephen J Gross, Amelia M Webb, Alek D Peterlin, Jessica R Durrant, Rachel J Judson, Qanber Raza, Jan K Kitajewski, Erich J Kushner
要旨

Collagen type IV (Col IV) is a basement membrane protein associated with early blood vessel morphogenesis and is essential for blood vessel stability. Defects in vascular Col IV deposition are the basis of heritable disorders, such as small vessel disease, marked by cerebral hemorrhage and drastically shorten lifespan. To date, little is known about how endothelial cells regulate the intracellular transport and selective secretion of Col IV in response to angiogenic cues, leaving a void in our understanding of this critical process. Our aim was to identify trafficking pathways that regulate Col IV deposition during angiogenic blood vessel development. We have identified the GTPase Rab10 as a major regulator of Col IV vesicular trafficking during vascular development using both in vitro imaging and biochemistry as well as in vivo models. Knockdown of Rab10 reduced de novo Col IV secretion in vivo and in vitro. Mechanistically, we determined that Rab10 is an indirect mediator of Col IV secretion, partnering with atypical Rab25 to deliver the enzyme lysyl hydroxylase 3 (LH3) to Col IV-containing vesicles staged for secretion. Loss of Rab10 or Rab25 results in depletion of LH3 from Col IV-containing vesicles and rapid lysosomal degradation of Col IV. Furthermore, we demonstrate that Rab10 is Notch responsive, indicating a novel connection between permissive Notch-based vessel maturation programs and vesicle trafficking. Our results illustrate both a new trafficking-based component in the regulated secretion of Col IV and how this vesicle trafficking program interfaces with Notch signaling to fine-tune basement membrane secretion during blood vessel development.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ペニシリン-ストレプトマイシン, Solution stabilized, with 10,000 units penicillin and 10 mg streptomycin/mL, 0.1 μm filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
シクロヘキシミド, from microbial, ≥94% (TLC)
Sigma-Aldrich
フィブリノーゲン ウシ血漿由来, Type I-S, 65-85% protein (≥75% of protein is clottable)
Sigma-Aldrich
トロンビン ウシ血漿由来, lyophilized powder, 40-300 NIH units/mg protein (biuret)
Sigma-Aldrich
アプロチニン ウシ肺由来, lyophilized powder, 3-8 TIU/mg solid
Sigma-Aldrich
抗ラミニン ウサギ宿主抗体, 0.5 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
DAPT, ≥98% (HPLC), solid
Sigma-Aldrich
クロロキン 二リン酸塩, powder or crystals, 98.5-101.0% (EP)
Sigma-Aldrich
血管内皮増殖因子 ヒト, VEGF, recombinant, expressed in E. coli, powder, suitable for cell culture
Sigma-Aldrich
抗IV型コラーゲン抗体, Chemicon®, from goat
Sigma-Aldrich
Anti-Heparan Sulfate Proteoglycan (Perlecan) Antibody, clone 5D7-2E4, clone 5D7-2E4, from mouse
Sigma-Aldrich
抗PLOD3 ウサギ宿主抗体, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-Rab10 Antibody, clone 4E2, ascites fluid, clone 4E2, from mouse